LXRX
Lexicon Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$959.46M
P/E Ratio
—
EPS
$-0.07
Beta
0.97
52W High
$2.53
52W Low
$0.61
50-Day MA
$1.79
200-Day MA
$1.45
Dividend Yield
—
Profit Margin
-37.50%
Forward P/E
—
PEG Ratio
-0.14
About Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.
Fundamentals
| Revenue (TTM) | $69.64M |
| Gross Profit (TTM) | $63.00M |
| EBITDA | $-23.63M |
| Operating Margin | -4.72% |
| Return on Equity | -16.00% |
| Return on Assets | -5.35% |
| Revenue/Share (TTM) | $0.19 |
| Book Value | $0.30 |
| Price-to-Book | 4.73 |
| Price-to-Sales (TTM) | 13.78 |
| EV/Revenue | 12.16 |
| EV/EBITDA | 16.57 |
| Quarterly Earnings Growth (YoY) | -63.40% |
| Quarterly Revenue Growth (YoY) | 1572.00% |
| Shares Outstanding | $444.20M |
| Float | $394.68M |
| % Insiders | 0.98% |
| % Institutions | 78.71% |
Historical Volatility
HV 10-Day
92.19%
HV 20-Day
95.98%
HV 30-Day
84.55%
HV 60-Day
71.97%
HV Rank
54.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($3.72 target)
1
Strong Buy2
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026